We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

105 hedge funds and large institutions have $351M invested in Taro Pharmaceutical Industries Ltd. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 29

6% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 18

1% more funds holding

Funds holding: 104 → 105 (+1)

21% less capital invested

Capital invested by funds: $444M → $351M (-$93.6M)

Holders
105
Holders Change
+1
Holders Change %
+0.96%
% of All Funds
2.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
38
Reduced
29
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$12.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.3M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.9M
4
OAC
OMERS Administration Corp
Ontario, Canada
+$2.82M
5
Morgan Stanley
Morgan Stanley
New York
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
AL
AJO LP
Pennsylvania
-$16.6M
2
FCH
Freestone Capital Holdings
Washington
-$10.3M
3
First Manhattan
First Manhattan
New York
-$3.81M
4
Invesco
Invesco
Georgia
-$3.52M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bessemer Group
76
Bessemer Group
New Jersey
$232K -$20K -202 -7%
CANY
77
Caxton Associates (New York)
New York
$230K – – –
QI
78
QS Investors
New York
$203K +$39.6K +400 +20%
CS
79
Credit Suisse
Switzerland
$203K +$41K +415 +21%
PAM
80
Panagora Asset Management
Massachusetts
$126K – – –
CBOA
81
Commonwealth Bank of Australia
Australia
$111K +$49.5K +500 +63%
BlackRock
82
BlackRock
New York
$98K – – –
Bank of Montreal
83
Bank of Montreal
Ontario, Canada
$71K – – –
CCM
84
Covington Capital Management
California
$64K – – –
QT
85
Quantbot Technologies
New York
$50K +$59K +596 New
Wells Fargo
86
Wells Fargo
California
$49K -$120K -1,212 -68%
OSAM
87
O'Shaughnessy Asset Management
Connecticut
$46K +$53.7K +543 New
EFSCE
88
Enterprise Financial Services Corp (EFSC)
Missouri
$35K – – –
RFA
89
Reilly Financial Advisors
California
$21K – – –
RIA
90
RPG Investment Advisory
California
$9K -$2.27K -23 -19%
LTFS
91
Ladenburg Thalmann Financial Services
Florida
$8K – – –
Nisa Investment Advisors
92
Nisa Investment Advisors
Missouri
$5K +$5.54K +56 New
Bank of America
93
Bank of America
North Carolina
$4K -$297 -3 -6%
AG
94
Advisor Group
Arizona
$4K – – –
FWM
95
Focused Wealth Management
New York
$3K – – –
Fifth Third Bancorp
96
Fifth Third Bancorp
Ohio
$3K +$2.97K +30 New
GRP
97
Global Retirement Partners
California
$3K +$3.17K +32 New
PB
98
Pinnacle Bancorp
Nebraska
$3K +$3.66K +37 New
FCH
99
Freestone Capital Holdings
Washington
$2.15K -$10.3M -104,636 -81%
HAM
100
Highstreet Asset Management
Ontario, Canada
$2K -$890 -9 -33%
1 2 3
4
5

TARO Hedge Fund Activity: Q2 2019 in Review

105 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2019, worth a combined $351M — down 21% from $444M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new TARO positions and 18 closed out — a net gain of 1 holder — while 38 added to existing stakes and 29 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $12.5M. The largest seller was AJO LP, cutting an estimated $16.6M.

  • 105 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2019, up from 104 in Q1 2019.
  • Funds reported $351M of Taro Pharmaceutical Industries Ltd. stock for Q2 2019, down 21% quarter-over-quarter.
  • 19 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2019 and 18 closed out, a net change of +1 holder.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2019 was Renaissance Technologies, an estimated $12.5M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2019 was AJO LP, an estimated $16.6M sold.

Based on aggregated 13F filings for Q2 2019.